| Literature DB >> 34703264 |
Xiuqin Shi1,2, Wenjing Cheng1,3,4, Qian Wang1, Jiachan Zhang1,3,4, Changtao Wang1,3,4, Meng Li1,3,4, Dan Zhao1,3,4, Dongdong Wang1,3,4, Quan An2.
Abstract
BACKGROUND: Ganoderma lucidum (G. lucidum) is one of China's traditional medicinal materials. G. lucidum polysaccharide has a wide range of promising pharmacological applications. However, there are many kinds of G. lucidum and they contain different kinds of polysaccharides. The biological mechanism through which Ganoderma lucidum polysaccharides (GLP) is able to protect human skin fibroblasts (HSFs) from H2O2-induced oxidative damage is still unclear.Entities:
Keywords: Ganoderma lucidum; Keap1-Nrf2/ARE signaling pathway; oxidative stress; polysaccharide
Year: 2021 PMID: 34703264 PMCID: PMC8525518 DOI: 10.2147/CCID.S334527
Source DB: PubMed Journal: Clin Cosmet Investig Dermatol ISSN: 1178-7015
Figure 1The antioxidant potential of GLPs at different concentrations. Scavenging effects of GLPs on DPPH-free radicals (A), ABTS-free radicals (B), hydroxyl radicals (C), and superoxide anion-free radicals (D). Results are expressed as mean ± SD (n = 3).
EC50 Value of Different Scavenging Abilities
| Samples | EC50 of GLPs (mg/mL) | EC50 of GLPs (mg/mL) | EC50 of GLPs (mg/mL) |
|---|---|---|---|
| DPPH | O2-· | ·OH | |
| GLP1 | 3.15±0.23 | 9.56±0.71 | 7.61±0.55 |
| GLP2 | 4.41±0.51 | 6.70±0.23 | 13.34±0.10 |
| GLP3 | 8.61±0.32 | 2.78±0.15 | 12.65±0.85 |
| GLP4 | 2.85±0.05 | 2.03±0.11 | 9.47±0.73 |
| GLP5 | – | 1.10±0.01 | – |
| GLP6 | 3.15±0.23 | 9.56±0.71 | 7.61±0.55 |
Figure 3Protective and reparative effects of GLP1, GLP1I, and GLP1II treated on H2O2-induced oxidative damaged HSFs. VC was considered as a positive control. (A1–E1) shows the protective effects of GLP1, GLP1I, and GLP1II. HSFs were pretreated respectively with GLP1, GLP1I, and GLP1II at the concentration of 1.25 g·L−1 followed by 100 μmol·L−1 H2O2 for 2 h. (A2–E2) shows the reparative effects of GLP1, GLP1I, and GLP1II. HSFs were pretreated with 100 μmol·L-1 H2O2 for 2 h, followed by GLP1, GLP1I, and GLP1II at the concentration of 1.25 g·L−1, respectively. (A1 and A2) catalase activities; (B1 and B2), GSH-Px activities; (C1 and C2) SOD activities; (D1 and D2) MDA contents; (E1 and E2) ROS levels represented by fluorescence intensity. Results are expressed as the mean ± SD (n = 3). The Student’s t-test was performed to determine statistical significance (**P < 0.01, ***P < 0.001, versus the control group; ###P < 0.001, versus the model group).